Dental Practice Valuation Multiples in Virginia (2026)

The average general practice in the ADA's own accounting produces $698,436 in annual revenue against $482,343 in expenses, with average GP net income of $207,980, according to ADA Health Policy Institute figures reported by Dental Economics. Pay the owner a market wage out of that and there is almost nothing left for a buyer to multiply. That is the uncomfortable arithmetic behind every conversation about valuation multiples in Virginia this year, and it is why we think most owners are negotiating the wrong number entirely.

Our view, stated plainly so you can argue with it: in 2026 the multiple is the least negotiable term in your deal, and a Virginia general practice collecting under roughly $1.2 million should stop pricing itself on an EBITDA multiple at all. Below that line you are not selling a cash-flowing asset. You are selling a job with equipment attached, and the owners who spend twelve months fighting a broker over 4.5x versus 5.5x are fighting over a number that was decided by their P&L three years ago.

Virginia's $187,950 Baseline Sets Your Floor

Every EBITDA calculation in a practice sale starts with the same subtraction: what would it cost to replace you? Not what you paid yourself, not what your accountant structured for tax reasons, but what the market charges for a dentist to do the clinical work you do.

In Virginia, that number has a public anchor. The Bureau of Labor Statistics counted 3,500 employed general dentists in the Commonwealth at an annual mean wage of $187,950, with a location quotient of 1.10, per the OEWS May 2023 state estimates. A location quotient above 1.0 means Virginia employs dentists at a higher concentration than the national average. Good for patients. Mildly inconvenient for sellers, because it means buyers in this market have no trouble arguing that replacement labor is available at or near that mean.

Run the ADA's average practice through that filter. Revenue of $698,436 less expenses of $482,343 leaves $216,093 of pre-owner cash flow. Normalize owner compensation to Virginia's $187,950 mean and you are left with $28,143 of EBITDA. At four times, that is $112,572 of enterprise value.

No buyer is writing that check against goodwill, and no seller would accept it. Which is the point: practices at that scale do not transact on multiples. They transact on hard assets, chair count, patient charts and a seller note, and the "multiple" is a narrative applied after the fact to make the price sound defensible. If someone quotes you a market multiple without first asking what your normalized owner comp is, they are selling you comfort.

What $162,050 Buys at 4x and at 5x

Now take a practice that has actually cleared the scale threshold. Say you collect $1,400,000 in a Richmond or Virginia Beach suburb, with total operating expenses before any owner compensation of $1,050,000. That is $350,000 of pre-owner cash flow.

Subtract the Virginia replacement wage of $187,950 and your defensible EBITDA is $162,050. At 4.0x, the enterprise value is $648,200. At 5.0x, it is $810,250. One full turn of multiple is worth $162,050 to you.

Here is the part owners underweight. One dollar of EBITDA is worth four to five dollars at closing, which means the add-back schedule is the single highest-stakes document in the transaction. Suppose you present $60,000 of personal expenses as add-backs: the vehicle, the continuing education trips that were mostly vacation, your spouse's payroll for bookkeeping nobody can document. A disciplined buyer disallows $35,000 of it. Your EBITDA drops to $127,050. At the same 5.0x you were arguing for, the value falls to $635,250. You just lost $175,000 by overreaching on $35,000 of expenses.

That is worse than it looks, because the disallowance also costs you credibility on every other line. Once a buyer catches one soft add-back, they re-underwrite the whole schedule at a discount. We'd rather see an owner submit a tight $25,000 of bulletproof add-backs than a padded $60,000, every time.

Most Owners Negotiate the Multiple and Give Away the EBITDA

The specific mistake, and it is overwhelmingly made by solo owners in years one and two of a planned exit: they treat the multiple as the variable and the EBITDA as a fact. It is exactly backwards. The multiple is set by things you cannot move in the year you sell, which include your collections scale, your payer mix, your associate coverage, your lease term and whether a buyer can operate the practice without you in the chair. The EBITDA is the thing you can actually move, and you have roughly 24 months of runway to move it before the trailing-twelve-month window closes on your exit.

The second version of this mistake is the owner who runs the practice for personal tax efficiency until the day they list it. Expensing aggressively through an S-corp is rational while you own the thing. It is expensive at exit, because every dollar you bury in a soft expense line is a dollar a buyer either disallows or discounts, and the discount runs at four to five times face value. Our call: 24 months out, stop optimizing for taxes and start optimizing for a clean P&L. The tax you save in year one is a fraction of the value you destroy at closing.

The third version, and the most common in Northern Virginia specifically: holding out for a DSO multiple on a practice that has no DSO-relevant scale. Group buyers pay premium multiples for platform characteristics, including multiple providers, a hygiene department that runs without the owner, and collections large enough to absorb corporate overhead. A single-provider practice at $900,000 does not have those. Waiting three years for a bid that is not coming costs you three years of a declining patient base.

The Fee Increase Two-Thirds of Dentists Already Took

There is a reason we are cautious on 2026 multiples rather than bullish. Two-thirds of dentists reported raising fees since the start of 2025 while appointment wait times continued to decline, according to ADA News reporting Health Policy Institute Q3 2025 data. Read those two facts together. Fees up, wait times down. That is not a market absorbing price increases from a position of strength. That is practices defending margin into softening demand, and buyers underwriting 2026 acquisitions know it.

It also changes how a fee increase shows up in your valuation. Take the $1,400,000 practice again. A 6% across-the-board fee increase on an identical procedure mix adds $84,000 of collections. Because you are doing the same cases with the same supplies and the same staff, nearly all of that flows to EBITDA. At an 85% flow-through, that is $71,400. At 5.0x, you just created $357,000 of enterprise value from a fee schedule update.

Now assume the ADA data is telling you something real and 4% of visits walk. Your new gross fee base is $1,484,000, so a 4% volume loss is $59,360 of collections. You do save variable cost on the procedures you no longer perform, call it 18% of the lost collections, or $10,685. Net EBITDA improvement: $35,325. At 5.0x, $176,625 of value.

The fee increase still wins, decisively. But it is worth half what the no-attrition version is worth, and that gap is the whole argument for raising fees while simultaneously doing the unglamorous work of filling the schedule. We wouldn't take a fee increase without a recall-reactivation push running alongside it.

Five Operatories, $200,000 Each

The asking side of the market tells you what buyers are sorting through. In The Dental Signal Practice Market Index, built from 925 dental practices currently listed for sale, the median listed practice reports collections of $957,588 (n=753), and for general practices specifically the median is $946,000 (n=644). The median listed practice has 5 operatories (n=754). Median collections per operatory run $200,000, with the middle half between $146,875 and $268,708 (n=643).

These describe practices on the market, not practices in general. But that is exactly the population a buyer compares you to, and the comparison is instructive. If you have 5 operatories and collect $1,000,000, you are at $200,000 per chair and you look like the middle of the listed field. If you have 7 operatories and collect the same $1,000,000, you are at roughly $143,000 per chair, and a buyer sees two idle rooms you are paying rent and debt service on. That shows up as a lower multiple, because unused capacity is evidence that the practice has a demand problem rather than a space problem.

Flip it. Those same idle operatories are the cheapest EBITDA you will ever buy, because the rent, the equipment and the sterilization area are already paid for. Adding one hygiene day in an empty room is close to pure margin, and at a 5x multiple it is the highest-return capital project available to most owners.

Where Virginia Actually Prices: $2.2M at 14% Margin

For an in-market reference point rather than a national benchmark, a Northern Virginia general practice generating $2.2 million in annual collections is listed at over 14% EBITDA margin on Commonwealth Transitions' Dentagraphics marketplace listings. Fourteen percent of $2.2 million is $308,000 of EBITDA. If a buyer paid 5.5x on that figure, the enterprise value would be $1,694,000.

The first question we'd ask about that listing is whether the 14% is calculated after normalizing owner compensation to something like Virginia's $187,950 mean, or before. At $2.2 million of collections, a practice is almost certainly running more than one provider, and the answer determines whether that margin is a real number or a marketing number. The gap between those two interpretations on a $2.2 million practice is worth several hundred thousand dollars of purchase price. Ask the question in writing, early, and get the answer in a reconciliation schedule rather than a conversation.

Three Things to Do Before You Call a Broker

Pull your last twelve months and calculate EBITDA with owner compensation normalized to $187,950, not to what you actually paid yourself. Build the add-back schedule now and delete every line you cannot support with a document, because padding costs four to five times face value when it gets caught. Then count your operatories, divide collections by that number, and if you are materially under $200,000 per chair, fix use before you fix your asking price.

We are watching two things that would move our view. If ADA wait times stop declining and fee increases start sticking without volume loss, 2026 multiples hold up better than we expect. And if verifiable Virginia transactions start closing at 5x on sub-$1 million practices with single providers, we are wrong about the scale threshold and will say so.

If you want to see where your own practice lands, our valuation calculator runs the same normalization: your collections, your expenses, your owner comp adjusted to the Virginia replacement wage, and the EBITDA a buyer would actually underwrite. It takes about four minutes and it will tell you whether you are arguing about the multiple or about the thing the multiple gets applied to. Run your own numbers before anyone else runs them for you.